Get started Log in

BIOBV — Biohit Oyj Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Market Cap
€33.15m
Enterprise Value
€31.65m
Revenue
€15.73m

Brief: Biohit starts a confirmatory smoking intervention trial
15/02/2016 07:30
Brief: Biohit acquires 18 pct stake in Genetic Analysis
05/01/2016 13:37
Brief: Biohit's ColonView test option in colorectal screening project in Russia
09/11/2015 09:00
Brief: Biohit: Acetium lozenge - a promising novel method to assist smoking cessation
04/11/2015 07:32
Brief: Biohit Q3 net sales stable at EUR 1.3 million
22/10/2015 07:30
Brief: Biohit: Promising results with Acetium lozenge in elimination of carcinogenic acetaldehyde in saliva
15/09/2015 07:30
Brief: Biohit signs distributor agreement with Daiichi Sankyo
01/09/2015 07:30
Brief: Biohit Q2 net sales up at 2.3 million euros
20/08/2015 07:30
Brief: Biohit GastroPanel tests to be used in gastric cancer screening study in China
16/07/2015 11:15
Brief: Biohit expands distribution of Acetium lozenge to dental care
12/06/2015 07:35
Brief: Biohit: modern colorectal cancer screening test on the market from Finland
12/05/2015 07:30
Brief: Biohit: European Parliament ask the EFSA to re-evaluate the use of acetaldehyde
06/05/2015 07:30
Brief: Biohit and Gulf Drug to sign distributor agreement
23/03/2015 07:30
Brief: Biohit and Oriola sign distribution agreement
10/03/2015 13:45
Brief: Biohit Q4 net sales up to EUR 1.1 million
26/02/2015 07:30
Brief: Biohit signs distribution agreement with Akeso Pharmaceuticals
17/02/2015 11:00
operation
29/01/2015 09:30
Brief: Biohit and Eurobio to sign a distributor agreement
22/12/2014 13:00
operate
12/12/2014 14:03
Brief: Biohit launches ColonView for colorectal cancer screening
03/11/2014 13:30